1L3 Stock Overview
Engages in the dental, demolition and tools, and systems solutions businesses in Sweden, Norway, Germany, rest of Europe, the United Kingdom, Asia, Australia, Italy, North America, and internationally. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 2/6 |
Past Performance | 2/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Lifco AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 12.20 |
52 Week High | SEK 13.90 |
52 Week Low | SEK 9.55 |
Beta | 1.41 |
11 Month Change | -1.61% |
3 Month Change | -5.43% |
1 Year Change | 31.89% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 74.29% |
Recent News & Updates
Recent updates
Shareholder Returns
1L3 | DE Industrials | DE Market | |
---|---|---|---|
7D | -6.2% | -6.4% | -1.3% |
1Y | 31.9% | 17.4% | 7.4% |
Return vs Industry: 1L3 exceeded the German Industrials industry which returned 17.7% over the past year.
Return vs Market: 1L3 exceeded the German Market which returned 7.1% over the past year.
Price Volatility
1L3 volatility | |
---|---|
1L3 Average Weekly Movement | 4.1% |
Industrials Industry Average Movement | 4.0% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.8% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 1L3 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 1L3's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1993 | 7,193 | Per Waldemarson | www.lifco.se |
Lifco AB (publ) engages in the dental, demolition and tools, and systems solutions businesses in Sweden, Norway, Germany, rest of Europe, the United Kingdom, Asia, Australia, Italy, North America, and internationally. It is involved in the distribution of dental equipment, such as denture attachments, disinfectants, saliva ejectors, bite registration and dental impression materials, bonding agents, and other consumables, as well as develops and sells medical record systems. The company also operates dental laboratory.
Lifco AB (publ) Fundamentals Summary
1L3 fundamental statistics | |
---|---|
Market cap | €12.23b |
Earnings (TTM) | €278.24m |
Revenue (TTM) | €2.20b |
44.0x
P/E Ratio5.6x
P/S RatioIs 1L3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
1L3 income statement (TTM) | |
---|---|
Revenue | SEK 25.45b |
Cost of Revenue | SEK 14.17b |
Gross Profit | SEK 11.28b |
Other Expenses | SEK 8.06b |
Earnings | SEK 3.23b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 31, 2025
Earnings per share (EPS) | 7.10 |
Gross Margin | 44.33% |
Net Profit Margin | 12.67% |
Debt/Equity Ratio | 54.1% |
How did 1L3 perform over the long term?
See historical performance and comparison